1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Iyad Naeem Muhammad, PhD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eradication of H. Pylori Infection With Moxifloxacin Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID, Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID - Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to | Phase 3 | Completed | Iyad Naeem Muhammad, PhD | 162 | 2020-06-01 | 2023-05-18 |
Amoxicillin (1) · BID protein, human (1) · Levofloxacin (1) · Moxifloxacin (1) · Omeprazole (1) · Tinidazole (1)
Pakistan (1)